Find uplifting stories about heroes, innovations, and solutions
7 results for "tzield"
Australia has approved Tzield, the first therapy in over 100 years that can delay the onset of type 1 diabetes by an average of two years. The breakthrough gives families precious time before the daily burden of insulin therapy begins.
Australia just approved the first new type 1 diabetes therapy since insulin was discovered over a century ago. The treatment can delay disease progression by an average of two years, giving families precious time before daily insulin begins.
Two children in British Columbia just became the first in Canada to receive a medication that can delay type 1 diabetes by years. This marks a turning point for families who have spent decades waiting for treatments that change the disease course, not just manage symptoms.
Two children at BC Children's Hospital became the first in Canada to receive a treatment that can delay type 1 diabetes by about two years. This marks a historic shift from just managing the disease to actually changing its course.
Australia just approved the first treatment in 100 years that can delay type 1 diabetes before symptoms even appear. Teplizumab gives families precious extra time without insulin therapy, fear, and constant medical monitoring.
A groundbreaking treatment can now delay type 1 diabetes for up to three years, giving families precious time before symptoms begin. The NHS has approved the first-ever drug that stops the disease in its tracks during early stages.
Australian patients diagnosed early with type 1 diabetes can now access a breakthrough therapy that delays their need for daily insulin by up to three years. The treatment marks the first time doctors can slow the disease before symptoms appear, rather than waiting until the body stops producing insulin.